Statements (34)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:CEO |
gptkb:Samantha_Du
|
gptkbp:collaboratesWith |
gptkb:Turning_Point_Therapeutics
gptkb:Novocure gptkb:Regeneron GlaxoSmithKline |
gptkbp:focusesOn |
infectious diseases
neurology oncology autoimmune diseases |
gptkbp:foundedIn |
2014
|
gptkbp:founder |
gptkb:Samantha_Du
|
gptkbp:headquartersLocation |
gptkb:Shanghai,_China
|
https://www.w3.org/2000/01/rdf-schema#label |
Zai Lab
|
gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
gptkbp:listedOn |
gptkb:Hong_Kong_Stock_Exchange
|
gptkbp:notableProduct |
gptkb:NUZYRA
gptkb:ODOMZO gptkb:QINLOCK gptkb:ZEJULA |
gptkbp:numberOfEmployees |
over 1,000
|
gptkbp:operatesIn |
gptkb:China
gptkb:United_States |
gptkbp:regionServed |
gptkb:Greater_China
gptkb:United_States gptkb:Asia-Pacific |
gptkbp:stockExchange |
gptkb:NASDAQ
|
gptkbp:stockSymbol |
gptkb:9688.HK
gptkb:ZLAB |
gptkbp:website |
https://www.zailaboratory.com/
|
gptkbp:bfsParent |
gptkb:Zhangjiang
gptkb:Qiming_Venture_Partners |
gptkbp:bfsLayer |
6
|